David Larwood

David has been their CEO since their founding in 2007. He has been leading their manufacturing process development, now in increasing scale GMP manufacturing. In his PhD studies in Pharmaceutical Chemistry at the University of California San Francisco he helped invent a successful drug delivery system (PEG liposomes, used in Doxil and other products). Earlier, he was first to synthesize Iotrolan, a commercially important contrast agent still in use decades later.

He is an experienced business executive with 19 years experience as VP or CEO. For 3 years he was VP and primary attorney of FormFactor, a startup company that has been successfully public since 2003. In 2001, he took Verisity Ltd. public as its General Counsel and remained in that role until the company was acquired in 2005.